Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126097592 | 12609759 | 2 | F | 20160707 | 20160718 | 20160801 | 20160801 | EXP | GB-MHRA-TPP9964479C403336YC1467912927893 | GB-CIPLA LTD.-2016GB10069 | CIPLA | 0.00 | Y | 0.00000 | 20160801 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126097592 | 12609759 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Buccal | 10 MG, UNK | U | U | 77044 | 10 | MG | ||||||
| 126097592 | 12609759 | 2 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Buccal | 20 MG, UNK | U | U | 77044 | 20 | MG | ||||||
| 126097592 | 12609759 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 1 DF, QD | 2714 | DF | U | U | 0 | 1 | DF | QD | |||
| 126097592 | 12609759 | 4 | C | Clarithormycin | 2 | Oral | 1 DF, ONCE 12 HOURS | 72 | DF | U | U | 0 | 1 | DF | |||||
| 126097592 | 12609759 | 5 | C | Codeine phosphate | CODEINE PHOSPHATE | 1 | Oral | 1 DF, QID, WHEN NEEDED | 248 | DF | U | U | 0 | 1 | DF | Q6H | |||
| 126097592 | 12609759 | 6 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Oral | 1 DF, QID, IF NEEDED | 248 | DF | U | U | 0 | 1 | DF | Q6H | |||
| 126097592 | 12609759 | 7 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Oral | 1 DF, QD | 1296 | DF | U | U | 0 | 1 | DF | QD | |||
| 126097592 | 12609759 | 8 | C | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | 1 DF, QD, EVERY MORNING | 1543 | DF | U | U | 0 | 1 | DF | QD | |||
| 126097592 | 12609759 | 9 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 1 DF, QD | 2337 | DF | U | U | 0 | 1 | DF | QD | |||
| 126097592 | 12609759 | 10 | C | REVAXIS | DIPHTHERIA AND TETANUS TOXOIDS AND POLIOVIRUS VACCINE ANTIGENS | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126097592 | 12609759 | 11 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | Oral | AS NECESSARY, ONE OR TWO TO BE TAKEN AT NIGHT FOR C... | U | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126097592 | 12609759 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126097592 | 12609759 | Agitation | |
| 126097592 | 12609759 | Feeling hot | |
| 126097592 | 12609759 | Hyperhidrosis | |
| 126097592 | 12609759 | Mood altered | |
| 126097592 | 12609759 | Serotonin syndrome | |
| 126097592 | 12609759 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126097592 | 12609759 | 3 | 20090130 | 0 | ||
| 126097592 | 12609759 | 4 | 20160601 | 20160608 | 0 | |
| 126097592 | 12609759 | 5 | 20160506 | 20160603 | 0 | |
| 126097592 | 12609759 | 6 | 20160506 | 20160531 | 0 | |
| 126097592 | 12609759 | 7 | 20121218 | 0 | ||
| 126097592 | 12609759 | 8 | 20120416 | 0 | ||
| 126097592 | 12609759 | 9 | 20100211 | 0 | ||
| 126097592 | 12609759 | 10 | 20160428 | 20160429 | 0 | |
| 126097592 | 12609759 | 11 | 20160506 | 20160605 | 0 |